ClinicalTrials.gg
CompletedNCT06728137Updated Aug 31, 2026Results posted

Investigation of a New Compression Bandage System Combining Skin Protection, Padding and Compression in One Single Bandage and Comparing to an Existing One-component Bandage.

An observational study in Healthy Volunteers, sponsored by Lohmann & Rauscher. Completed at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Lohmann & Rauscher · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
22
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to learn about the pressure that can be maintained by a new compression bandage over the course of seven days in healthy volunteers. This bandage combines skin protection, padding and compression in one single bandage. It will be applied to the participants lower legs. A similar device will be applied to the other lower leg of the participant. A randomisation method is used for the assignment of the bandages to the participants legs.

Researchers will compare the bandage pressures of both bandages. The so-called sub-bandage pressure will be measured at the day of application and on the next day, the third day and the last day. Participants will also be asked about the wearing comfort of both bandages.

02

Conditions studied

  • Healthy Volunteers

Keywords

  • prospective
  • monocentric
  • randomized controlled trial
03

In context

Lead sponsor

Lohmann & Rauscher is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Apparently healthy volunteers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy intact skin with no clinical signs of chronic venous insufficiency and no signs of any dermatological condition such as eczema or psoriasis as assessed by investigating physician.
  • Ankle circumference > 18 cm (2 cm above ankle) as assessed by the investigating physician.

Exclusion criteria

Exclusion Criteria:

  • Known sensitivity to the study products (Rosidal 1C or Urgo K1) or any of their components
  • Chronic venous disease with CEAP ≥2
  • Ankle Brachial Pressure Index (ABPI) \< 0.8 or >1.3
  • Ankle circumference \<18 or > 32 cm
  • Venous echo-Doppler with recognizable abnormalities
  • History of

    • malignant ulcer
    • clinically infected wound
    • peripheral arterial occlusive diseases,
    • cardiac insufficiency or cardiac disease such as congestive heart failure, coronary artery disease, myocardial infarction, coronary artery bypass graft
    • cerebrovascular disease
    • liver or renal disease
    • septic phlebitis,
    • phlegmasia coerulea dolens,
    • sensation disorders of the skin
    • eczema, psoriasis
  • Use of diuretics, antihypertension or drugs that influence the capillary infiltration
  • Comorbidities that could affect compression therapy, particularly diseases causing oedema
  • Reliable severe malnutrition
  • Diabetes Mellitus
  • > 30 kg/m2
  • Pregnancy or breast feeding
  • Participation in an interventional clinical trial within the last 3 months and during participation in this study
  • Participant is analphabet
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
22 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy Volunteers
06

What researchers measure

Primary outcomes

  1. Static Stiffness Index SSI

    The static stiffness index is the sub-bandge pressure difference between active standing and lying.

    Time frame: Day 0

Secondary outcomes

  1. Sub-bandage Resting Pressure After One Week of Contionous Wearing of the Comprression Bandages

    The sub-bandage resting pressures are measured during muscle relaxation or rest when the participant is lying.

    Time frame: Day 0 + 6 days

  2. Number of Participants Assessing the Wearing Comfort by Ankle Mobility as Acceptable or Better

    Participants were asked on the last day how they rate the ankle mobility when wearing the bandages, using a 6-point scale from insufficient, poor, acceptable, good, very good, to excellant.

    Time frame: Day 0 + 6 days

07

Results

Posted Aug 31, 2026

Participant flow

Investigational Device

Participant flow — Overall Study
MilestoneInvestigational DeviceComparator Device
Started2222
Completed1919
Not completed33

Outcome measures

PrimaryStatic Stiffness Index SSI

The static stiffness index is the sub-bandge pressure difference between active standing and lying.

Time frame:
Day 0
Reported as:
Mean · mmHg
Static Stiffness Index SSI
mmHgInvestigational DeviceComparator Device
Static Stiffness Index SSI10 ± 712 ± 9
SecondarySub-bandage Resting Pressure After One Week of Contionous Wearing of the Comprression Bandages

The sub-bandage resting pressures are measured during muscle relaxation or rest when the participant is lying.

Time frame:
Day 0 + 6 days
Reported as:
Mean · mmHg
Sub-bandage Resting Pressure After One Week of Contionous Wearing of the Comprression Bandages
mmHgInvestigational DeviceComparator Device
Sub-bandage Resting Pressure After One Week of Contionous Wearing of the Comprression Bandages19 ± 912 ± 7
SecondaryNumber of Participants Assessing the Wearing Comfort by Ankle Mobility as Acceptable or Better

Participants were asked on the last day how they rate the ankle mobility when wearing the bandages, using a 6-point scale from insufficient, poor, acceptable, good, very good, to excellant.

Time frame:
Day 0 + 6 days
Reported as:
Count of participants · Participants
Number of Participants Assessing the Wearing Comfort by Ankle Mobility as Acceptable or Better
ParticipantsInvestigational DeviceComparator Device
Number of Participants Assessing the Wearing Comfort by Ankle Mobility as Acceptable or Better18 ± 1318 ± 12.5

Adverse events

Collected over From enrollment until end of follow-up, one week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Investigational Device0/22 (0%)0/22 (0%)1/22 (4.5%)
Comparator Device0/22 (0%)0/22 (0%)1/22 (4.5%)
Most frequent other events
Most frequent other events
EventInvestigational DeviceComparator Device
Allergy against one component within the investigational and comparator bandageSkin and subcutaneous tissue disorders1/221/22

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Healthy Volunteers
<=18 years0
Between 18 and 65 years22
>=65 years0
Age, Continuous
Age, Continuous(years)Healthy Volunteers
Mean33 (21 to 57)
Sex: Female, Male
Sex: Female, Male(Participants)Healthy Volunteers
Female14
Male8
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Healthy Volunteers
Region of Enrollment
Region of Enrollment(participants)Healthy Volunteers
Italy22
08

Study locations

1 site
  • Department of Clinical and Experimental Medicine, University of Pisa, UOC Dermatologia Universitaria, Santa Chiara Hospital AOUP
    Pisa, 56126, Italy
09

References and documents

Publications

  • Dini V, Vietina A, Michelucci A, Rizzello F, Romanelli M, Mosti G, Namislo A, Bohm C, Abel M. A prospective, monocentric, observational randomised controlled pilot study of two all-in-one multicomponent compression systems in healthy volunteers. J Wound Care. 2026 Jan 2;35(1):26-34. doi: 10.12968/jowc.2025.0456. PubMed 41528788 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in Mar 2025, 1 month.

Results were first posted in Aug 2026, 1 year 5 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2024
First posted
Dec 11, 2024
StartActual
Jan 14, 2025
Primary completionActual
Mar 3, 2025
CompletionActual
Apr 20, 2025
Results first posted
Aug 31, 2026
Last update
Aug 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06728137
Lead sponsor
Lohmann & Rauscher
Responsible party
Sponsor
First posted
Dec 11, 2024
Start date
Jan 14, 2025
Primary completion
Mar 3, 2025
Completion
Apr 20, 2025
Results posted
Aug 31, 2026
Last update
Aug 31, 2026

Study contacts

Prof. Dr. Valentina Dini
principal investigator · Department of Clinical and Experimental Medicine, University of Pisa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion